|
RBM15B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.049100E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.784700E-04 |
| Normal-vs-Stage2 |
6.040200E-01 |
| Normal-vs-Stage3 |
3.973600E-01 |
| Normal-vs-Stage4 |
6.083000E-01 |
| Stage1-vs-Stage2 |
1.355620E-01 |
| Stage1-vs-Stage3 |
1.967210E-01 |
| Stage1-vs-Stage4 |
7.595700E-02 |
| Stage2-vs-Stage3 |
7.803600E-01 |
| Stage2-vs-Stage4 |
4.806800E-01 |
| Stage3-vs-Stage4 |
4.104800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.376900E-04 |
| Normal-vs-AfricanAmerican |
2.641900E-02 |
| Normal-vs-Asian |
5.335600E-01 |
| Caucasian-vs-AfricanAmerican |
4.202800E-01 |
| Caucasian-vs-Asian |
1.691960E-01 |
| AfricanAmerican-vs-Asian |
1.922770E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.899400E-03 |
| Normal-vs-Female |
2.15839999999634E-05 |
| Male-vs-Female |
9.257200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.130500E-02 |
| Normal-vs-Extreme_Weight |
2.618200E-02 |
| Normal-vs-Obese |
3.504600E-03 |
| Normal-vs-Extreme_Obese |
6.679500E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.684600E-01 |
| Normal_Weight-vs-Obese |
4.016000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.113200E-01 |
| Extreme_Weight-vs-Obese |
4.752600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.102200E-01 |
| Obese-vs-Extreme_Obese |
7.866200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.85579999999663E-05 |
| Normal-vs-Age(41-60Yrs) |
1.583400E-04 |
| Normal-vs-Age(61-80Yrs) |
1.822250E-02 |
| Normal-vs-Age(81-100Yrs) |
6.874400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.961800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.034400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.838300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.232400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.782800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.144600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.82150000042014E-07 |
| Normal-VS-Type2 PRCC |
3.928400E-01 |
| Normal-VS-KIRP CIMP |
2.502900E-03 |
| Normal-VS-Unclassified PRCC |
9.856700E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.09200000042442E-07 |
| Type1 PRCC-VS-KIRP CIMP |
8.461200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.745800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.155600E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.820320E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
5.501200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.252400E-01 |
| Normal-vs-N1 |
1.987640E-01 |
| Normal-vs-N2 |
4.712600E-01 |
| N0-vs-N1 |
1.813410E-01 |
| N0-vs-N2 |
6.212000E-01 |
| N1-vs-N2 |
8.706000E-01 |
|
|
